Literature DB >> 34799486

Fatty liver and cerebrovascular disease: plausible association and possible mechanisms.

Sahil Khanna1, Neal S Parikh2, Lisa B VanWagner1,3.   

Abstract

PURPOSE OF REVIEW: Nonalcoholic fatty liver disease (NAFLD) is a common comorbidity and has wide ranging extrahepatic manifestations, including through cardiometabolic pathways. As such, there is growing interest in the impact of NAFLD on cerebrovascular disease and brain health more broadly. In this review, we assess recent research into understanding the association between NAFLD and brain health while highlighting potential clinical implications. RECENT
FINDINGS: Mechanistically, NAFLD is characterized by both a proinflammatory and proatherogenic state, which results in vascular inflammation and neurodegeneration, potentially leading to clinical and subclinical cerebrovascular disease. Mounting epidemiological evidence suggests an association between NAFLD and an increased risk and severity of stroke, independent of other vascular risk factors. Studies also implicate NAFLD in subclinical cerebrovascular disease, such as carotid atherosclerosis and microvascular disease. In contrast, there does not appear to be an independent association between NAFLD and cognitive impairment.
SUMMARY: The current literature supports the formulation of NAFLD as a multisystem disease that may also have implications for cerebrovascular disease and brain health. Further prospective studies are needed to better assess a temporal relationship between the two diseases, confirm these early findings, and decipher mechanistic links.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2022        PMID: 34799486      PMCID: PMC8702469          DOI: 10.1097/MOL.0000000000000799

Source DB:  PubMed          Journal:  Curr Opin Lipidol        ISSN: 0957-9672            Impact factor:   4.616


  50 in total

Review 1.  NAFLD: a multisystem disease.

Authors:  Christopher D Byrne; Giovanni Targher
Journal:  J Hepatol       Date:  2015-04       Impact factor: 25.083

Review 2.  Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases.

Authors:  Leon A Adams; Quentin M Anstee; Herbert Tilg; Giovanni Targher
Journal:  Gut       Date:  2017-03-17       Impact factor: 23.059

3.  Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular disease in adult patients with type 1 diabetes.

Authors:  Alessandro Mantovani; Lucia Mingolla; Riccardo Rigolon; Isabella Pichiri; Valentina Cavalieri; Giacomo Zoppini; Giuseppe Lippi; Enzo Bonora; Giovanni Targher
Journal:  Int J Cardiol       Date:  2016-10-17       Impact factor: 4.164

4.  Carotid Intima-Media Thickness and Markers of Brain Health in a Biracial Middle-Aged Cohort: CARDIA Brain MRI Sub-study.

Authors:  Pavla Cermakova; Jie Ding; Osorio Meirelles; Jared Reis; Dorota Religa; Pamela J Schreiner; David R Jacobs; R Nick Bryan; Lenore J Launer
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2020-01-20       Impact factor: 6.053

5.  Histological Features of Cerebellar Neuropathology in Patients With Alcoholic and Nonalcoholic Steatohepatitis.

Authors:  Tiziano Balzano; Jerónimo Forteza; Irene Borreda; Pilar Molina; Juan Giner; Paola Leone; Amparo Urios; Carmina Montoliu; Vicente Felipo
Journal:  J Neuropathol Exp Neurol       Date:  2018-09-01       Impact factor: 3.685

6.  Association between PNPLA3 rs738409 G variant and MRI cerebrovascular disease biomarkers.

Authors:  Neal S Parikh; Nicole Dueker; Dalila Varela; Victor J Del Brutto; Tatjana Rundek; Clinton B Wright; Ralph L Sacco; Mitchell S V Elkind; Jose Gutierrez
Journal:  J Neurol Sci       Date:  2020-06-20       Impact factor: 3.181

7.  Non-alcoholic fatty liver disease, liver biomarkers and stroke risk: The Reasons for Geographic and Racial Differences in Stroke cohort.

Authors:  Kristine S Alexander; Neil A Zakai; Steven D Lidofsky; Peter W Callas; Suzanne E Judd; Russell P Tracy; Mary Cushman
Journal:  PLoS One       Date:  2018-03-12       Impact factor: 3.240

8.  Non-alcoholic fatty liver disease and cognitive function in middle-aged adults: the CARDIA study.

Authors:  Yariv Gerber; Lisa B VanWagner; Kristine Yaffe; James G Terry; Jamal S Rana; Jared P Reis; Stephen Sidney
Journal:  BMC Gastroenterol       Date:  2021-03-02       Impact factor: 3.067

9.  PNPLA3 GG genotype and carotid atherosclerosis in patients with non-alcoholic fatty liver disease.

Authors:  Salvatore Petta; Luca Valenti; Giulio Marchesini; Vito Di Marco; Anna Licata; Calogero Cammà; Maria Rosa Barcellona; Daniela Cabibi; Benedetta Donati; Anna Fracanzani; Stefania Grimaudo; Gaspare Parrinello; Rosaria Maria Pipitone; Daniele Torres; Silvia Fargion; Giuseppe Licata; Antonio Craxì
Journal:  PLoS One       Date:  2013-09-17       Impact factor: 3.240

Review 10.  Macrophages in obesity and non-alcoholic fatty liver disease: Crosstalk with metabolism.

Authors:  Sander Lefere; Frank Tacke
Journal:  JHEP Rep       Date:  2019-02-23
View more
  1 in total

1.  Does nonalcoholic fatty liver disease predispose patients to carotid arteriosclerosis and ischemic stroke?

Authors:  Qian Jin; Rui-Xu Yang; Jian-Gao Fan
Journal:  Clin Mol Hepatol       Date:  2022-06-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.